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a b s t r a c t
Chromatin regulators contribute to the developmental control of gene expression. In the nematode
Caenorhabditis elegans, the roles of chromatin regulation in development have been explored in several
contexts, including vulval differentiation. The synthetic multivulva (synMuv) genes are regulators of
vulval development in C. elegans and the proteins encoded by these genes include components of several
histone modiﬁcation and chromatin remodelling complexes. By inhibiting ectopic expression of the
epidermal growth factor (LIN-3) in the nematode hypodermis, the synMuv genes prevent inappropriate
vulval induction. In a forward genetic screen for modiﬁers of the expression of a hypodermal reporter
gene, we identiﬁed a mutation that results in increased expression of the reporter. This mutation also
suppresses ectopic vulval induction in synMuv mutants and we have consequently named the affected
gene suppressor of synthetic multivulva-1 (sumv-1). We show that SUMV-1 is required in the
hypodermis for the synMuv phenotype and that loss of sumv-1 function suppresses ectopic expression
of lin-3 in synMuv mutant animals. In yeast two-hybrid assays SUMV-1 physically interacts with SUMV-
2, and reduction of sumv-2 function also suppresses the synMuv phenotype. We identiﬁed similarities
between SUMV-1 and SUMV-2 and mammalian proteins KAT8 NSL2 and KAT8 NSL3, respectively, which
are components of the KAT8/MOF histone acetyltransferase complex. Reduction of function of mys-2,
which encodes the enzymatic component of the KAT8/MOF complex, also suppresses the synMuv
phenotype, and MYS-2 physically interacts with SUMV-2 in yeast two-hybrid assays. Together these
observations suggest that SUMV-1 and SUMV-2 may function together with MYS-2 in a nematode KAT8/
MOF-like complex to antagonise the activity of the synMuv genes.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Developmental control of gene expression requires the regulation
of chromatin. In chromatin, DNA is packaged into nucleosomes in
which 200 bp of DNA are associated with an octamer of histone
proteins and linker histones (Bell et al., 2011). The tails of histone
proteins protrude from the nucleosome and are subject to extensive
post-translational modiﬁcations, including acetylation, methylation
and phosphorylation (Bannister and Kouzarides, 2011). These post-
translational modiﬁcations can alter the interaction between histones
and DNA and can also be recognised by histone readers (Musselman et
al., 2012). Histone readers can additionally possess their own enzy-
matic activities to add or remove histone tail modiﬁcations or may
recruit other regulatory complexes to chromatin, including ATP-
dependent chromatin-remodelling complexes (Maltby et al., 2012).
The latter complexes inﬂuence chromatin structure through the
mobilisation of nucleosomes or their histone subunits.
In the nematode Caenorhabditis elegans, the roles of chromatin
regulation in development have been explored in several contexts,
including vulval differentiation. Vulva development in C. elegans is
determined by the LIN-3/EGF and LIN-12/Notch signalling path-
ways and is investigated as a model of differentiation in develop-
mental biology and to interrogate signalling pathways in cancer
biology. The vulva is derived from specialised cells in the ventral
hypodermis called vulval precursor cells (VPCs). In the C. elegans
larva there are six VPCs, which all have the potential to divide and
differentiate into vulval cells. At the third larval stage (L3), the
nematode epidermal growth factor, called LIN-3 (Hill and
Sternberg, 1992), is secreted from a cell in the gonad called the anchor
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cell. This signal instructs three of the VPCs to execute vulval fates, such
that they divide in a stereotypic manner to ultimately produce the 22
vulval cells which constitute the mature vulva. The remaining three
VPCs divide once then fuse with the surrounding hypodermis (Sulston
and Horvitz, 1977). If the VPCs are insufﬁciently induced, a vulvaless
(Vul) phenotype arises. Conversely, the induction of vulval fates in
additional VPCs gives rise to the multiple vulva or multivulva (Muv)
phenotype, characterised by the presence of ectopic protrusions along
the ventral side of the worm (Beitel et al., 1990; Han et al., 1990; Katz
et al., 1996).
A group of genes called the synthetic multivulva genes (synMuv)
act redundantly to repress vulval differentiation (Ferguson and
Horvitz, 1989; Horvitz and Sulston, 1980). These genes inhibit the
ectopic expression of the LIN-3/EGF growth factor in the large
hypodermal cell called hyp7 (a syncytium with 139 nuclei), thereby
preventing additional VPCs from being induced to execute vulval cell
fates (Cui et al., 2006a; Myers and Greenwald, 2005; Saffer et al., 2011).
The synMuv genes are divided into classes, for example, class A
synMuv and class B synMuv. While single mutation of most synMuv
genes does not lead to robust over-induction of the VPCs, the
simultaneous mutation of two synMuv genes from different classes,
that is, a class A synMuv and class B synMuv, yields a Muv phenotype.
To date, at least 30 synMuv genes have been identiﬁed (Andersen and
Horvitz, 2007; Davison et al., 2011; Fay and Yochem, 2007; Tseng et al.,
2007) and many of these genes encode proteins that regulate
chromatin structure. For instance, nematode members of the nucleo-
some remodelling and histone deacetylase (NuRD) complex and a
Tip60/NuA4-like histone acetyltransferase complex are among the
proteins encoded by synMuv genes (Ceol and Horvitz, 2004; Solari and
Ahringer, 2000).
Several studies have identiﬁed genetic antagonists of the
synMuv genes, which have been called synMuv suppressor genes
(Andersen et al., 2006; Cui et al., 2006b; Simms and Baillie, 2010;
Wang et al., 2005). Mutation or reduction of function by RNA
interference (RNAi) of the synMuv suppressor genes in a synMuv
mutant background leads to suppression of ectopic vulval induc-
tion. Many of the synMuv suppressor genes encode proteins with
proposed or demonstrated roles in chromatin regulation. These
include components of NURF-like (Andersen et al., 2006) and
SWR1-like (Cui et al., 2006b) chromatin remodelling complexes.
We describe here the characterisation of sumv-1/C34E10.8, which
had been identiﬁed as a synMuv suppressor gene by Cui et al. (2006b).
We isolated a mutant allele of sumv-1 in a screen for modiﬁers of the
expression of a hypodermal gfp reporter. We show that SUMV-1 is a
broadly expressed nuclear factor that is required in the hypodermis for
the synMuv phenotype. Using yeast two-hybrid assays we demon-
strate that SUMV-1 physically interacts with DPY-30, a component of
both the Set1/MLL histone methyltransferase complex and the dosage
compensation complex, and with SUMV-2/F54D11.2. Like SUMV-1,
both SUMV-2 and DPY-30 are required for the synMuv phenotype. We
ﬁnd that SUMV-1 and SUMV-2 share similarities with human proteins
KAT8 NSL2 and KAT8 NSL3, respectively, which are components of the
KAT8/MOF histone acetyltransferase complex. Furthermore, we show
that mys-2, which encodes the nematode homologue of the KAT8/
MOF histone acetyltransferase, is also required for the synMuv
phenotype. Together these data indicate a role for a KAT8/MOF-like
complex in antagonising the function of the synMuv genes in the
hypodermis of C. elegans.
Materials and methods
Nematode strains and maintenance
Nematode strains were cultured according to standard techni-
ques (Sulston and Hodgkin, 1988). Experiments were carried out at
20 1C unless otherwise stated. Mutagenesis with 0.05 M ethyl-
methanesulfonate was performed as described (Brenner, 1974).
The animals described as wild type were C. elegans, variety Bristol,
strain N2. The Hawaiian strain CB4856 was used for mapping
experiments using single nucleotide polymorphisms (SNP) that
modify a restriction site (snip-SNP) as described (Davis et al.,
2005). The following strains were used:
N2 (Bristol)
JCB34 ctbp-1(eg613),
HRN054 ausIs1[pctbp-1::ctbp-1::gfp],
HRN088 ausIs1[pctbp-1::ctbp-1::gfp]; sumv-1(aus3),
HRN097 sumv-1(aus3),
HRN099 ausIs1[pctbp-1::ctbp-1::gfp]; sumv-1(aus3); ausEx23
[psumv-1::sumv-1þpRF4[rol-6(su1006)]],
HRN101 ausIs1[pctbp-1::ctbp-1::gfp]; sumv-1(aus3); ausEx24
[pRF4[rol-6(su1006)]],
HRN110 ausEx25[psumv-1::sumv-1::gfpþpRF4[rol-6(su1006)]],
HRN111 sumv-1(aus3); qIs56[lag-2::gfp(pJK590)],
HRN125 sumv-1(aus3); lin-15AB(n765),
HRN128 sumv-1(aus3); ccIs4251[pmyo-3::GFP::LacZþpmyo-3::
GFPþdpy-20],
HRN140 lin-15AB(n765) (outcrossed from AA790 lin-15AB
(n765); dhEx343),
HRN173 ctbp-1(tm5512),
HRN190 sumv-1(aus3); lin-15AB(n765); ausEx23[psumv-1::
sumv-1þpRF4[rol-6(su1006)]],
HRN192 lin-15AB(n765) ctbp-1(eg613),
HRN213 sumv-1(aus3); lin-15AB(n765) ctbp-1(eg613),
HRN216 lin-35(n745); lin-8(n111); sumv-1(aus3),
HRN217 stIs10166[pdpy-7::HIS-24::mcherry þunc-119]; ausIs1
[pctbp-1::ctbp-1::gfp],
HRN224 ausEx40[pdpy-7::sumv-1::V5þpmyo-2::mCherry],
HRN225 sumv-1(aus3); lin-15AB(n765); ausEx40[pdpy-7::sumv-
1::V5þpmyo-2::mCherry],
HRN274 lin-35(n745); lin-15A(n767),
HRN336 lin-15AB(n765) ctbp-1(tm5512),
HRN350 sumv-1(aus3); lin-15AB(n765) ctbp-1(tm5512),
HRN365 ausEx69[psumv-1::sumv-1::gfpþpCFJ90(pmyo-2::
mcherry)],
JK2868 qIs56[lag-2::gfp(pJK590)],
MT12839 lin-61(n3809); lin-8(n2731),
MT1624 lin-35(n745); lin-8(n111),
MT1643 lin-36(n766); lin-15A(n767),
MT16529 lin-61(n3477); lin-15A(n767),
SD1347 ccIs4251[pmyo-3::GFP::LacZþpmyo-3::GFPþdpy-
20], and
SD1546 ccIs4251[pmyo-3::GFP::LacZþpmyo-3::GFPþdpy-20];
stIs10166[pdpy-7::HIS-24::mCherryþunc-119].
Generation of ﬂuorescent reporter strains
The full-length ctbp-1 open reading frame with 2 kb 50 ﬂanking
region (corresponding to nucleotides 1685–13462 of cosmid
F49E10) and the full-length sumv-1 open reading frame with
1.9 kb 50 ﬂanking region (corresponding to nucleotides 22459–
29251 of cosmid C34E10) were ampliﬁed from N2 genomic DNA.
These amplicons were fused to the green ﬂuorescent protein (GFP)
coding sequence ampliﬁed from pPD95.75 (Hobert, 2002). The
ctbp-1::gfp fusion product was injected at a concentration of
50 ng/μL into the gonad of N2 hermaphrodites as described
(Mello and Fire, 1995). Of three extrachromosomal arrays gener-
ated, one was selected for integration. Fourth larval stage (L4)
animals were gamma irradiated at a dose of 3600 Rads. Two
second generation (F2) progeny from each of 500 ﬁrst generation
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(F1) broods were singled and the resulting 1000 plates screened
for 100% GFP animals. One line carrying an integrated transgene
(ausIs1[pctbp-1::ctbp-1::gfp]) was identiﬁed and subsequently
backcrossed to N2 six times to remove secondary mutations
induced by radiation. Conventional snip-SNP mapping (Davis et
al., 2005) showed the ausIs1 insertion to be on the right arm of
linkage group (LG) I. The sumv-1::gfp fusion product was injected
together with pRF4 [rol-6(su1006)] (Mello and Fire, 1995), which is
denoted as rol-6(dm), with dm indicating a dominant mutation, as
a co-transformation marker, both at a concentration of 50 ng/μL,
into N2 hermaphrodites. One extrachromosomal array was gener-
ated. Additional transgenic lines were generated by injecting the
sumv-1::gfp fusion product (50 ng/ml) together with pCFJ90 (pmyo-
2::mcherry) (Frokjaer-Jensen et al., 2008) (2.5 ng/ml) as a co-
transformation marker.
Primer details:
GFP forward (F): AGCTTGCATGCCTGCAGGTCG
GFP reverse (R): AAGGGCCCGTACGGCCGACTA
GFP nested: GGAAACAGTTATGTTTGGTATA
ctbp-1F: GATAACTCTCTTGTTGTATTTGG
ctbp-1R: AGTCGACCTGCAGGCATGCAAGCTTGTGGC
CAATGGTTGCTCATC
ctbp-1 nested: AGCATTACTCGAAAGTTGTCG
sumv-1F: GACCCACACAACAAGCTACG
sumv-1R: AGTCGACCTGCAGGCATGCAAGCTAAGTTCCTCCT-
CATATTCCTC
sumv-1 nested: ACGATCACAGATGAACAG
Quantiﬁcation of relative ﬂuorescence intensity
Fluorescence images were captured on a BX51 Microscope
(Olympus) using AnalySIS software (Olympus). The GFP ﬂuores-
cence in hypodermal and neuronal nuclei of mid-L4 animals
carrying the ausIs1[pctbp-1::ctbp-1::gfp] was quantiﬁed using Ima-
geJ. To avoid interfering ﬂuorescence signals, a region 50 mm
anterior to the rectum was analysed. For neuronal ﬂuorescence,
the region was a 6010 mm2 rectangle along the length of the
ventral nerve cord. Images were taken with neuronal nuclei in
focus. For hypodermal ﬂuorescence, the region was a 6020 mm2
rectangle (containing on average 7.5 hypodermal nuclei) along the
length of the worm and not including the ventral nerve cord.
Images were taken with hypodermal nuclei in focus. The inte-
grated density in the selected regions was quantiﬁed and cor-
rected by subtracting the mean ﬂuorescence of the background.
The corrected total ﬂuorescence was then normalised to the wild-
type signal to derive a relative ﬂuorescence intensity.
The GFP ﬂuorescence in distal tip cells (qIs56[lag-2::gfp
(pJK590)]) and muscle cells (ccIs4251[pmyo-3::GFP::LacZþpmyo-
3::GFPþdpy-20]) was similarly quantiﬁed in ImageJ. For the
former, a region of ﬁxed size centred on the distal tip cell was
selected, while for the latter, a region of ﬁxed size centred on the
vulva was selected with reference to a corresponding bright-
ﬁeld image.
Whole-genome sequencing and data analysis
Genomic DNA extracted from a lab reference strain and the
aus3 mutant was sequenced by the Australian Genome Research
Facility using the Illumina GAII platform, yielding an average 12
coverage. MAQGene software was used to analyse raw sequencing
ﬁles (Bigelow et al., 2009). Variants appearing in both the
reference and aus3 mutant strain were excluded. All remaining
variants identiﬁed in aus3 on LGIII, to which aus3 had been
localised using snip-SNP mapping, were re-sequenced with stan-
dard Sanger sequencing.
Rescue of the aus3 mutation
The sumv-1 locus, including 5 kb upstream of the start site of
translation along with 325 bases downstream of the stop codon
(corresponding to positions 22155–32370 of cosmid C34E10), was
ampliﬁed from N2 genomic DNA using the Expand Long Template
polymerase chain reaction (PCR) system (Roche). The ampliﬁed
product was injected into strain HRN088 ausIs1[pctbp-1::ctbp-1::
gfp], sumv-1(aus3) with plasmid pRF4[rol-6(su1006)] as a co-
transformation marker, both at 50 ng/ml. To generate a control
strain, pRF4[rol-6(su1006)] was injected alone at 50 ng/ml.
Genotyping and strain construction
The single nucleotide polymorphism of sumv-1(aus3) was
detected with tetra-primer ampliﬁcation-refractory mutation sys-
tem (ARMS) PCR (Ye et al., 2001) using outer primers sumv-1genoF
and sumv-1genoR and inner allele-speciﬁc primers sumv-1wtF
and sumv-1aus3R. The deletion–insertion of lin-15AB(n765) was
detected using standard PCR protocols and primers lin-15genoF
and lin-15genoR. The single nucleotide polymorphism of ctbp-1
(eg613) creates a DraI site and was detected using standard PCR
protocols with primers ctbp-1eg613genoF and ctbp-1eg613genoR
followed by restriction digestion. The deletion of ctbp-1(tm5512)
was detected using standard PCR protocols with primers
ctbp1tm5512_F, ctbp1tm5512_del_R, and ctbp1tm5512_R.
ctbp1tm5512_del_R lies in the deletion and will only generate a
product from wild-type worms. To generate strains HRN192 lin-
15AB(n765) ctbp-1(eg613) and HRN336 lin-15AB(n765) ctbp-1
(tm5512), homozygous lin-15AB(n765) animals were identiﬁed by
the Muv phenotype in the self progeny of lin-15AB(n765) þ /þ
ctbp-1(eg613) or lin-15AB(n765) þ /þ ctbp-1(tm5512) hermaphro-
dites and recombinants were identiﬁed by genotyping for the
ctbp-1(eg613) or ctbp-1(tm5512) allele.
Primer details:
sumv-1genoF: CTTCTCAAACTTTTCGATCTCAAG
sumv-1genoR: TGATGCCAGTAGCAATGAATT
sumv-1wtF: GAACAGCTTGAGGGCTCTG
sumv-1aus3R: TAAATACAAACCCCGAAGCC
lin-15genoF: ACAAACATTCGTCGTTCCG
lin-15genoR: TTTCATTGTCAATGTAGTGGAGG
ctbp-1eg613genoF: CTTCGAGCAAGAGCATTCGG
ctbp-1eg613genoR: CTGTCATCCATGCTGAATGAGG
ctbp1tm5512_F: TGGCACCATTGCATAACGTTTCTGT
ctbp1tm5512_del_R: GCCTCCTTCAAAGTGAGCCGAGC
ctbp1tm5512_R: ACCTGACGGCGACTCTGGTCT
Analysis of vulval development
The Muv phenotype was scored by examining young adult
animals with a dissecting microscope. Animals with one or more
ectopic ventral protrusions were considered to be Muv. The
percentage of animals displaying the Muv phenotype was deter-
mined in three or four independently-cultured populations for
each genotype. We report the percentage of animals displaying the
Muv phenotype (% Muv) across all assayed populations. Fisher's
exact tests were used to compare % Muv scores between different
genotypes or RNAi treatments.
Vulval induction was scored by examining the number of VPCs
that have adopted vulval cell fates at the L4 stage using differential
interference contrast microscopy. The number of daughter cells
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derived from each VPC (P3.p–P8.p) was counted. If the VPC
produced 7–8 daughter cells, it was scored as 1 (fully induced).
If the VPC produced 3–4 daughter cells, it was scored as 0.5. A VPC
which only divided once and fused with the hypodermis was
scored 0. Using this scheme, a wild-type animal will have a score
of 3 induced VPCs and a score greater than 3 indicates ectopic
vulval induction (Moghal et al., 2003). A one-way ANOVA with
Tukey post-test was used to compare mean induction scores
between genotypes.
RNAi
HT115(DE3) bacterial cells containing RNAi feeding clones from
the Vidal lab RNAi library (Rual et al., 2004) or pL4440-RNAi-dest-
sumv-1 (see “plasmid constructs” below) were grown overnight in
50 mL LB liquid cultures containing ampicillin (100 mg/mL) at
37 1C. dsRNA expression was induced by the addition of IPTG
(3 mM). After three hours incubation, the induced cultures were
concentrated by centrifugation and spread on day-old NGM/
carbenicillin (25 mg/mL) plates with freshly-added IPTG (3 mM).
These cultures were further induced at room temperature for 24 h.
Approximately thirty synchronized ﬁrst larval stage (L1) worms
were added to the plates which were cultured at 20 1C. The Muv
phenotype was scored in the second generation progeny of these
animals at the young–adult stage by dissecting microscope as
described above.
Real-time RT-PCR
Synchronised L1 wild-type and mutant animals (sumv-1(aus3))
were grown on NGM plates seeded with OP50 until the worms
reached the third larval stage (L3). Worms were then harvested
and frozen in liquid nitrogen before being crushed with a plastic
pestle. Samples were then applied to a Qiashredder column
(Qiagen) before using the RNeasy puriﬁcation kit (Qiagen) to
extract the RNA, which was subsequently treated with rDNaseI
(Ambion). Random-primed cDNA was synthesised from the pur-
iﬁed total RNA (3 mg) using the SuperScripts III First Strand
Synthesis for RT-PCR (Invitrogen) kit. The RT-PCR reactions were
prepared using Fast SYBRs Green Master Mix (Applied Biosystems,
4385612) and ctbp-1 and sumv-1 primers listed were used at a
concentration of 125 nM in a ﬁnal volume of 20 μL. The PCR
ampliﬁcation was achieved using a 7500 Fast Real-time PCR
System (Applied Biosystems) under the default thermal cycling
conditions. The ctbp-1 and sumv-1 mRNA levels were normalised
against the levels of ubc-2 mRNA. The data were analysed using
the standard curve method. Student's t test was used for statistical
analysis.
Primer details:
ctbp_b_F: AAGCGGAAACGAAATCCAGC
ctbp_b_R: TCATCCTTGTGCTCGTCATAC
rt_3to4_ctbp1aF: CCGTCAGGTGACAGTCCATC
rt_3to4_ctbp1aR: AAGTCACGAAAACTCCGGCT
C34E10RT-F_AD: AGCTGTTCGGCGACAAACTCCAG
C34E10RT-R_AD: GTATGCTGGGAGCCCGAAGCC
C34E10RT-F_BC: TCCACAGCCTCGTTTCCCAGT
C3410RT-R_BC: TGGAACACCGCGTCTCGATGG
ubc-2L: AGGGAGGTGTCTTCTTCCTCAC
ubc-2R: CGGATTTGGATCACAGAGCAGC
Single molecule ﬂuorescence in situ hybridisation (smFISH)
The expression of lin-3 was examined by smFISH. Fixation of
worms and hybridisation of probes was performed as in Raj et al.
(2008) with two modiﬁcations: probes were used at 25 mM concen-
tration and formamide concentration in hybridisation and wash
buffers was 20%. Images are presented as maximum intensity
projections of a z-stack of slices at most 1 mm thick. Probes speciﬁc
for the lin-3 transcript were as previously reported (Saffer et al.,
2011). These probes, conjugated to CAL Fluor Red 610 ﬂuorophore,
were purchased from Stellaris. Fluorescence was achieved using an
excitation wavelength of 575 nm for a duration of 1 s per slice.
Fluorescent spots 200–500 nm in size in the maximum intensity
projections were counted using StarSearch, a programme developed
by M. Levesque and A. Raj at the University of Pennsylvania (http://
rajlab.seas.upenn.edu/StarSearch/launch.html). Tissue boundaries
were drawn based on corresponding DIC images and spots were
counted in the pharynx, germline, anchor cell and the tail region
(denoted as “leaky” expression). Counting in the tail was performed
on an image of the posterior portion of the worm. An equivalent area
was drawn for all images of all genotypes. The posterior portion of
the worm was chosen to score leaky expression to avoid under-
estimating the number of spots due to photobleaching or over-
estimating the number of spots due to background ﬂuorescence. We
report an average number of spots (7 standard deviation (S.D.)) for
each tissue type. A one-way ANOVAwith Sidak post-test was used to
compare lin-3 smFISH counts between genotypes.
Plasmid constructs
Plasmids were constructed using Gateway© recombination
cloning (Invitrogen). sumv-1, sumv-2, dpy-30 and mys-2 cDNAs
were ampliﬁed from a C. elegans mixed stage cDNA library (RIKEN
RDB 1864) using gene-speciﬁc primers. Following a second round
of ampliﬁcationwith primers containing attB1 and attB2 sites (with
the exception that the mys-2 cDNA was ampliﬁed in a single PCR
round), PCR products were inserted into pDONR221 using BP
recombination (Invitrogen). Clones were veriﬁed by sequencing
before being inserted into destination vectors using LR recombina-
tion (Invitrogen). The sumv-1 cDNA was inserted into pL4440-
RNAi-dest (Rual et al., 2004) and sumv-1, sumv-2 and dpy-30 cDNAs
were inserted into pGBKT7g and pGADT7g (Rajagopala et al., 2007).
The mys-2 pDONR221 clone was digested with ApaI and EcoRV to
isolate themys-2 cDNAwith att sites intact. This fragment was then
inserted into pGBKT7g and pGADT7g using LR recombination.
A hypodermis-speciﬁc sumv-1 expression construct was gener-
ated with Multisite Gateways cloning (Invitrogen). The dpy-7
promoter (Gilleard et al., 1997) was ampliﬁed from wild-type
genomic DNA, using primers containing attB4 and attB1 sites, and
inserted into pDONRP4P1R using BP recombination to generate a 50
entry clone. The V5 coding sequence was fused to the 30 end of the
sumv-1 cDNA by PCR ampliﬁcation with a primer containing the V5
sequence. Following a second round of ampliﬁcation with primers
containing attB1 and attB2 sites, the sumv-1::V5 PCR product was
inserted into pDONR221 using BP recombination (Invitrogen) to
generate a middle entry clone. pCM5.37 containing the unc-54 30
UTR (Merritt et al., 2008) was used as the 30 entry clone. The three
entry clones were recombined into pBCN40-R4R3 (Semple et al.,
2012) (containing the pmyo-2::mcherry transformation marker) by
LR recombination using LR Clonases II enzyme mix (Invitrogen). The
expression construct was introduced into N2 worms using biolistic
transformation and dual antibiotic selection was used to isolate a
transgenic line as described (Semple et al., 2012). This line was then
crossed with sumv-1(aus3); lin-15AB(n765) animals to generate the
hypodermis-speciﬁc sumv-1-expressing strain HRN225.
Western blot
At least 1000 animals were lysed by heating to 95 1C in 6
Laemmli buffer. Proteins were separated on a precast NuPage 10%
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Bis–Tris polyacrylamide gel (Invitrogen) and electroblotted onto a
nitrocellulose membrane. The membrane was blocked in TBST
containing 5% skim milk followed by overnight incubation with
mouse anti-V5 (R960-25, Invitrogen) or rabbit anti-actin (sc-1615-
R, Santa Cruz Biotechnology) primary antibodies (1:1000). ECL™
anti-mouse (NA931V) or ECL™ anti-rabbit (NA934V) HRP second-
ary antibody (1:2000) (GE Healthcare) was subsequently applied
for one hour. The membrane was developed using the catalytic
oxidation of luminol in the presence of peroxide.
Yeast two-hybrid assays
The Clontech yeast two-hybrid system was used according to
the manufacturer's protocols. Yeast strain HF7c was transformed
with test constructs in pGBKT7g and pGADT7g vectors. Yeast
transformants were selected on –Leu–Trp plates. Colonies were
picked from these transformant plates and incubated overnight in
SD–Leu–Trp. The cultures were normalised to an OD600 of 1 and
serial dilutions were made. 10 mL was then pipetted on to –Leu–
Trp plates and –His–Leu–Trp plates, which were incubated at 30 1C
for 72 h.
Statistical analysis
All statistical analyses were performed using GraphPad Prism
Version 6.00 for Windows, GraphPad Software, La Jolla
California, USA.
Results
The aus3 allele alters CTBP-1::GFP expression in the hypodermis
In wild-type animals carrying the ausIs1[pctbp-1::ctbp-1::gfp]
transgene, CTBP-1::GFP is expressed in the nervous system (DY
and AR unpublished) and in the hypodermis. Within the hypo-
dermis, CTBP-1::GFP is observed both in the seam cells and, at
lower levels, in the nuclei of the hypodermal syncytium, hyp7. The
identity of these cells was conﬁrmed by observation of co-
localisation of CTBP-1::GFP with HIS-24::mcherry that is
expressed under the control of the hypodermal-speciﬁc promoter
of the dpy-7 gene (Fig. 1A). Due to higher levels of expression of
the HIS-24::mcherry reporter, spatial co-localisation is shown as
orange when the gfp and mcherry images are merged. With the
aim of discovering genes that regulate CTBP-1, a population of
animals carrying the ausIs1[pctbp-1::ctbp-1::gfp] transgene were
treated with EMS and the second generation self-progeny of these
mutagenised animals were screened for any change in the level or
pattern of CTBP-1::GFP expression. 6000 haploid genomes were
screened and eight mutants were isolated. One mutant, ausIs1
[pctbp-1::ctbp-1::gfp]; aus3, was selected for further study.
Compared with wild-type animals (Fig. 1B), the ausIs1[pctbp-1::
ctbp-1::gfp]; aus3mutant shows increased levels of CTBP-1::GFP in
hyp7 nuclei (Fig. 1C) but no detectable difference in the level of
CTBP-1::GFP expression in the nervous system. Quantiﬁcation of
the average ﬂuorescence intensity revealed that the level of CTBP-
1::GFP in hyp7 is 1.5 fold higher in aus3mutants than in wild-type
animals (po0.01, Student's t test), while no difference in the level
of CTBP-1::GFP in neurons was detected between the strains
(Fig. 1D). To determine whether the observed increase in expres-
sion of CTBP-1::GFP in hyp7 in aus3 mutant animals is due to a
change in cell number, the number of GFP-expressing nuclei in a
ﬁxed area of hyp7 were counted in both wild-type and aus3
mutant animals. No signiﬁcant difference in the number of GFP-
expressing nuclei was detected; an average (7SD) of 7.370.9
cells were observed in wild-type animals (n¼10) and 7.770.8
cells were observed in ausmutant animals (n¼10) (not signiﬁcant,
Student's t test).
The aus3 mutation is in gene C34E10.8/sumv-1
snip-SNP mapping identiﬁed the centre of LGIII as the approx-
imate genomic location of the aus3 mutation (Supplementary
materials, Table S1). Whole-genome sequencing was then per-
formed to identify variants in the aus3 mutant genome. Mutations
which were identiﬁed on LGIII were re-sequenced using standard
Sanger sequencing. In this way 10 candidate mutations which
could be causative of the aus3 mutant phenotype were conﬁrmed.
Of these, three affect non-coding sequences and six are missense
mutations. The ﬁnal mutation is a nonsense mutation; a C to T
substitution at position 2041 of the C34E10.8 predicted cDNA,
changing a Gln codon to a stop codon (Fig. 1E). We focused on this
gene as the most promising candidate and named it sumv-1 (for
suppressor of synthetic multivulva).
To test whether the sumv-1 gene could complement the
original mutation, we ﬁrst prepared a transgene. The entire coding
region of sumv-1, along with 5 kb upstream of the start site of
translation and 325 bases downstream of the stop codon was
ampliﬁed by PCR from wild-type genomic DNA. Stable transgenic
lines carrying this PCR product along with a co-transformation
marker plasmid pRF4 (containing the rol-6(su1006) allele which
confers a dominant Roller phenotype) were generated by micro-
injection. Lines carrying only the co-transformation marker were
also generated as a control. In both cases, the animals also carried
the ausIs1[pctbp-1::ctbp-1::gfp] transgene and the aus3 mutation.
These lines were used to determine whether the sumv-1 gene
could restore wild-type CTBP-1::GFP expression to the aus3
mutant. Introduction of the co-transformation marker alone did
not alter CTBP-1::GFP expression (Fig. 1F), while introduction of
both the co-transformation marker and the wild-type sumv-1
genomic region reduced the expression of CTBP-1::GFP in hyp7
of aus3 mutants (Fig. 1G). Thus, the transgene carrying the wild-
type sumv-1 genomic region successfully rescued the aus3 mutant
phenotype.
We next tested whether the sumv-1(aus3) mutation affected
the expression of other transgenes. No difference in the ﬂuores-
cence intensity of a gfp reporter driven by the lag-2 promoter
(qIs56), which directs expression in the distal tip cells of the
somatic gonad (Blelloch et al., 1999), was detected between wild
type and sumv-1(aus3) mutant animals (Supplementary materials
Fig. S1A and S1B). Similarly, no difference in the ﬂuorescence
intensity of a gfp reporter driven by themyo-3 promoter (ccIs4251),
which directs expression in the body wall muscles (Liu et al.,
2009), was detected between wild type animals and sumv-1(aus3)
mutant animals (Supplementary materials, Fig. S1C and S1D).
Since the aus3 mutation that was identiﬁed in sumv-1 is a
nonsense mutation, the mRNA may be subject to nonsense
mediated decay (NMD) (Stalder and Muhlemann, 2008). In order
to test this, real-time RT-PCR was used to quantify sumv-1 mRNA
levels in aus3 mutants compared with wild-type animals. Two
regions of the sumv-1 transcript were assayed corresponding to
nucleotide positions 1556–1700 (before the premature stop
codon) and 2057–2203 (after the premature stop codon) of the
sumv-1 cDNA. Reduced levels of sumv-1 mRNA were found in aus3
mutants compared with wild-type animals, suggesting that the
mutant sumv-1 transcript in aus3 mutants may be partially
degraded by NMD (Fig. 1H). The remaining transcripts that are
not degraded by NMD would encode a truncated protein of 680 aa
rather than the full-length 1024 aa protein. This truncated protein
may retain some activity, in which case aus3 may be a hypo-
morphic allele of sumv-1 rather than a null allele.
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SUMV-1 is broadly expressed in somatic cells
Towards clarifying how SUMV-1 controls expression of the
ausIs1[pctbp-1::ctbp-1::gfp] transgene in hyp7, the pattern of
expression of SUMV-1 was assessed. For this purpose, transgenic
animals carrying a psumv-1::sumv-1::gfp reporter construct were
generated by microinjection. The reporter construct was made by
PCR fusion and is composed of the entire coding sequence of
sumv-1 fused to the gfp coding sequence, under the control of the
putative sumv-1 promoter (2 kb upstream of the start site of
translation). Transgenic animals carrying the psumv-1::sumv-1::gfp
reporter show broad expression of the SUMV-1::GFP fusion
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sumv-1(aus3); ausEx24[rol-6(dm)] sumv-1(aus3); ausEx23[sumv-1+rol-6(dm)]
Fig. 1. Reduction of sumv-1 function increases hypodermal expression of CTBP-1::GFP. (A) From left to right: DIC, GFP, mCherry and merged GFP and mCherry ﬂuorescence
micrographs of an L4 hermaphrodite carrying the ausIs1[pctbp-1::ctbp-1::gfp] and stIs10166[pdpy-7::HIS-24::mcherry þunc-119] transgenes. (B) DIC (upper panel) and
ﬂuorescence (middle panel) micrographs of an L4 hermaphrodite carrying the ausIs1[pctbp-1::ctbp-1::gfp] transgene. (C) DIC (upper panel) and ﬂuorescence (middle panel)
micrographs of an sumv-1(aus3) mutant L4 hermaphrodite carrying the ausIs1[pctbp-1::ctbp-1::gfp] transgene. D) Quantiﬁcation of CTBP-1::GFP ﬂuorescence intensity in
wild-type and sumv-1 mutant L4 hermaphrodites. Values shown are mean ﬂuorescence intensity expressed relative to wild type for 3 independent experiments (10 worms
per strain per experiment) and error bars represent S.D. *po0.05 by two-way ANOVAwith Bonferroni post-test.( E) Structure of the sumv-1 gene. Exons are depicted as black
boxes and introns as lines. The position of the aus3 mutation is indicated by an arrowhead. (F) DIC (upper panel) and ﬂuorescence (middle panel) micrographs of an sumv-1
(aus3) mutant L4 hermaphrodite carrying the ausIs1[pctbp-1::ctbp-1::gfp] transgene and the ausEx24[rol-6(dm)] extrachromosomal array containing only the transformation
marker. (G) DIC (upper panel) and ﬂuorescence (middle panel) micrographs of an sumv-1(aus3) mutant L4 hermaphrodite carrying the ausIs1[pctbp-1::ctbp-1::gfp] transgene
and the ausEx23[psumv-1::sumv-1þrol-6(dm)] extrachromosomal array containing the transformation marker and wild-type sumv-1. Scale bars in A–C, F and G represents
50 mm. Representative nuclei of the hypodermal syncytium, hyp7, are indicated by arrows and neuronal nuclei are indicated by arrowheads in the enlarged regions of interest
shown as lower panels in B, C, and F–H) Relative sumv-1 expression levels in wild-type and sumv-1(aus3) mutant hermaphrodites were measured using real time RT-PCR
with ubc-2 as a normalisation control. Amplicons in exons 12–13 and exons 15–16 were assayed. Data shown are mean7SD for three independent populations.
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throughout all larval stages and in adulthood in many somatic
cells. Expression was observed in neuronal and intestinal cells and
in the hypodermis (Fig. 2A and B). In the majority of cells, GFP
ﬂuorescence is primarily localised to the nucleus. In contrast, in a
single pair of neurons, expression is seen not only in the nucleus
but also throughout the cytoplasm including neuronal projections
which run the length of the animal in the ventral nerve cord
(Fig. 2C).
Since reduction of SUMV-1 function affects transgene expres-
sion in the hypodermis, we speciﬁcally examined hypodermal
expression. Expression of SUMV-1::GFP was observed in hypoder-
mal nuclei, including those of hyp7, throughout larval develop-
ment and in to adulthood (Fig. 2D–G).
Reduction of SUMV-1 function suppresses the synMuv phenotype
C34E10.8/sumv-1 is one of several genes that was implicated in
vulval development by a large-scale RNAi screen for suppressors of
the synMuv phenotype. The screen performed by Cui et al. (2006)
identiﬁed 32 RNAi treatments which suppressed the synMuv
phenotype of a lin-15AB(n765) mutant (Cui et al., 2006b). The
mutant allele n765 disrupts the function of both the class A
synMuv gene lin-15A and the class B synMuv gene lin-15B (Clark
et al., 1994). To conﬁrm that loss of sumv-1 function suppresses the
synMuv phenotype, and thus that sumv-1 plays a role in the vulval
development, we carried out an RNAi feeding experiment, scoring
the Muv phenotype by dissecting microscope. We generated a
sumv-1 RNAi feeding construct and conﬁrmed that knockdown of
sumv-1 suppresses the synMuv phenotype of lin-15AB(n765); 91%
of lin-15AB(n765) animals fed on empty vector (EV) RNAi bacteria
were Muv, while only 4% of sumv-1 RNAi-treated animals were
Muv (Table 1). We additionally tested the effect of sumv-1 RNAi on
expression of the ausIs1[pctbp-1::ctbp-1::gfp] trangene and found
that, like the aus3 mutation, reduction of sumv-1 function by RNAi
resulted in increased expression of CTBP-1::GFP in the hypodermis
(1.2 fold) but no change in neuronal expression (Supplementary
materials, Fig. S2). We then assessed whether the aus3mutation in
sumv-1 could also suppress the synMuv phenotype of lin-15AB
(n765). While 100% of lin-15AB(n765) mutants are Muv, only 21%
of the sumv-1(aus3); lin-15AB(n765) double mutants showed this
phenotype, conﬁrming that reduction of sumv-1 function can
suppress the synMuv phenotype (Table 1 and Fig. 3).
To conﬁrm that the suppression of the synMuv phenotype
observed in the lin-15AB(n765); sumv-1(aus3) double mutants is
genuinely attributable to the aus3 mutation of sumv-1, we intro-
duced a transgene carrying wild-type copies of the sumv-1 locus.
This transgene, which rescued the hypodermal overexpression of
the ausIs1[pctbp-1::ctbp-1::gfp] transgene, also substantially res-
cued the synMuv suppression phenotype. That is, while 21% of
sumv-1(aus3); lin-15AB(n765) animals are Muv, 79% of sumv-1
(aus3); lin-15AB(n765) ausEx23[psumv-1::sumv-1] animals are Muv
(Table 1).
To further examine the effect of the sumv-1(aus3) mutation on
vulval development, we also examined vulval induction using DIC
Fig. 2. SUMV-1 is expressed in many somatic cells and is primarily localised to the nucleus. (A–C) DIC (left panel) and ﬂuorescence (middle and right panels) micrographs of
L4 hermaphrodites showing SUMV-1::GFP expression. The right panel shows an enlarged area of interest. (D–G) DIC (left panel) and ﬂuorescence (right panel) microscopes
of hermaphrodites showing SUMV-1::GFP expression in an L1 animal (D), an L2 animal (E), an L3 animal (F) and an L4 animal (G). Arrowheads mark representative neuronal
nuclei in A and neuronal cell bodies in C. Asterisks mark representative intestinal nuclei in B. Arrows indicate hypodermal nuclei in A, B, and D–G. Scale bar in A–G represents
50 mm.
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microscopy. The preceding assays of the Muv phenotype were
performed at 20 1C and at that temperature we observed over-
induction of vulval precursor cells in the lin-15AB(n765) mutant
alone while wild-type levels of vulval induction were observed in
the sumv-1(aus3); lin-15AB(n765) mutants (Table 2).
Since the penetrance of the synMuv phenotype is dependent
on temperature (Ferguson and Horvitz, 1989), we tested the
temperature dependence of the synMuv suppression phenotype
caused by the sumv-1(aus3) mutation by examining vulval induc-
tion also at 15 1C and 25 1C. At the lower temperature, vulval
induction in the lin-15AB(n765) mutant was not signiﬁcantly
different from that of wild type, and vulval induction was not
altered by the sumv-1(aus3) mutation at this temperature
(Table 2). At 25 1C, signiﬁcant over-induction of vulval precursor
cells was observed in the lin-15AB(n765) mutants, as expected. At
this higher temperature, over-induction was also observed in the
sumv-1(aus3); lin-15AB(n765) (Table 2). That is, at high tempera-
ture the aus3 mutation in sumv-1 does not suppress the over-
induction of vulval precursor cells due to lin-15AB(n765) mutation.
To further explore the synMuv suppression capacity of reduc-
tion of sumv-1 function, we examined whether reduction of sumv-
1 could suppress the synMuv phenotype of ﬁve other double
mutant strains. Using RNAi, we found that knockdown of sumv-1
suppressed the synMuv phenotype of lin-36(n766); lin-15A(n767)
mutants (EV 84% Muv, sumv-1 RNAi 8% Muv), consistent with the
ﬁndings of Cui et al. (2006b). We also found suppression of the
synMuv phenotype of lin-61(n3809); lin-8(n2731) (EV 27% Muv,
sumv-1 RNAi 4% Muv) and lin-61(n3477); lin-15A(n767) mutants
(EV 50% Muv, sumv-1 RNAi 29% Muv). However, reduction of sumv-
1 function by RNAi did not suppress the synMuv phenotype of lin-
35(n745); lin-8(n111) or lin-35(n745); lin-15A(n767) (Table 3).
Reduction of sumv-1 function by the aus3 mutation also did not
suppress the synMuv phenotype of lin-35(n745); lin-8(n111) (lin-
35(n745); lin-8(n111) 99% Muv (n¼552), lin-35(n745); lin-8(n111)
sumv-1(aus3) 100% Muv (n¼199)). While these observations
indicate that the synMuv suppression arising from reduction of
sumv-1 function is not restricted to the n765 allele of lin-15AB, they
also suggest that reduction of sumv-1 function does not universally
suppress synMuv phenotypes.
SUMV-1 activity in the hypodermis is required for the synMuv
phenotype
The synMuv genes are required in the hypodermal syncytium,
hyp7, to prevent ectopic expression of lin-3 in this tissue (Cui et al.,
2006a; Saffer et al., 2011). One possible mode of synMuv suppres-
sor activity may therefore be to antagonise synMuv activity in
hyp7. We tested whether re-expression of SUMV-1 solely in the
hypodermis could rescue the synMuv suppression phenotype of
the sumv-1(aus3) mutant. To this end we generated a transgenic
line expressing the sumv-1 cDNA under the control of the dpy-7
promoter, for hypodermal-speciﬁc expression (Gilleard et al.,
1997). We tagged SUMV-1 at the C-terminus with the short
epitope tag V5 to enable detection of SUMV-1 expressed from
the transgene. A transgenic line carrying this expression construct
as an extrachromosomal array was generated by biolistic trans-
formation and dual antibiotic selection (Semple et al., 2012).
Expression of SUMV-1 from the transgene was conﬁrmed by
immunoblotting with an anti-V5 antibody (Fig. 4A). A strain
carrying this transgene along with the sumv-1(aus3); lin-15AB
Table 1
Reduction of sumv-1 function suppresses the synMuv phenotype. The multivulva
(Muv) phenotype was scored in lin-15AB(n765) mutants after feeding on empty
vector (EV) or sumv-1 RNAi bacteria and in lin-15AB(n765) mutants alone or in
combination with the sumv-1(aus3) mutation with or without a transgene array
expressing wild-type sumv-1.
Genotype/treatment % Muv n
lin-15AB(n765) on EV 91 358
lin-15AB(n765) on sumv-1 RNAi 4nnnna 484
lin-15AB(n765) 100 174
sumv-1(aus3); lin-15AB(n765) 21nnnnb 96
sumv-1(aus3); lin-15AB(n765); ausEx23[psumv-1::sumv-1] 79nnnnc 109
nnnn po0.0001.
a EV treatment.
b lin-15AB(n765).
c sumv-1(aus3); lin-15AB(n765) in Fisher’s exact tests.
wild type
lin-15AB(n765)
sumv-1(aus3); lin-15AB(n765)
Fig. 3. Reduction of sumv-1 function suppresses the synMuv phenotype. Bright
ﬁeld micrographs of adult C. elegans hermaphrodites. The wild-type animal has no
pseudovulvae (upper panel), the lin-15AB(n765) mutant has three pseudovulvae
(middle panel) and the sumv-1(aus3); lin-15AB(n765) mutant has no pseudovulvae
(lower panel). Scale bar represents 200 mm and the position of vulvae and
pseudovulvae are indicated by arrows and arrowheads, respectively.
Table 2
Reduction of function of sumv-1 alters vulval induction in lin-15AB(n765) mutants
in a temperature-dependent manner. Animals were cultured at the speciﬁed
temperatures until the L4 stage at which vulval induction was scored using
differential interference contrast microscopy.
Genotype Temperature
(1C)
Average # P(3–8).p vulval
fates7SE
n
Wild type 15 370 33
sumv-1(aus3) 15 370 34
lin-15AB(n765) 15 3.370.1 (n.s.a) 39
sumv-1(aus3); lin-15AB
(n765)
15 3.670.1 (n.s.b) 41
Wild type 20 370 37
sumv-1(aus3) 20 370 31
lin-15AB(n765) 20 5.670.1****c 33
sumv-1(aus3); lin-15AB
(n765)
20 3.370.1****d 41
Wild type 25 370 31
sumv-1(aus3) 25 370 28
lin-15AB(n765) 25 5.570.1****e 22
sumv-1(aus3); lin-15AB
(n765)
25 5.470.1 (n.s.f) 30
nnnn po0.0001; n.s. not signiﬁcant. p-Values were calculated by one-way
ANOVA with Tukey post-test.
a Wild type at 15 1C and lin-15AB(n765) at 15 1C.
b lin-15AB(n765) at 15 1C and sumv-1(aus3); lin-15AB(n765) at 15 1C.
c wild type at 20 1C and lin-15AB(n765) at 20 1C.
d lin-15AB(n765) at 20 1C and sumv-1(aus3); lin-15AB(n765) at 20 1C.
e Wild type at 25 1C and lin-15AB(n765) at 25 1C
f lin-15AB(n765) at 25 1C and sumv-1(aus3); lin-15AB(n765) at 25 1C.
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(n765) mutations was then generated and the Muv phenotype was
scored in both the transgenic and non-transgenic progeny of
transgenic parents. Transgenic animals were identiﬁed by the
presence of red ﬂuorescence in the pharynx, indicative of the
pmyo-3::mcherry transformation marker. In the transgenic progeny
83% were Muv, while only 22% of the non-transgenic progeny
were Muv (Fig. 4B and C, 69 Muv out of 83 transgenic progeny, 20
Muv out of 90 non-transgenic progeny). Re-expression of sumv-1
in the hypodermis was thus found to substantially rescue the
synMuv suppressor phenotype of the sumv-1(aus3) mutant, indi-
cating that the cell type in which sumv-1 is required for the
synMuv phenotype is the hypodermis. Mosaic loss of the extra-
chromosomal transgene array may account for the incomplete
rescue of the synMuv suppression phenotype.
Given that the synMuv phenotype arises as a result of ectopic
expression of lin-3 in the hypodermis, we tested whether sumv-1
contributes to the regulation of lin-3 expression by visualising lin-
3 transcripts in whole worms at the late L2–early L3 stage using
smFISH (Raj et al., 2008; Saffer et al., 2011). In wild-type animals,
lin-3 expression was largely restricted to the pharynx, anchor cell
and developing germline (Fig. 4D), consistent with previous
reports (Saffer et al., 2011). The pattern of expression was similarly
restricted in sumv-1(aus3) mutant animals (Fig. 4E). In contrast, in
lin-15AB(n765) mutant animals, while expression was observed in
the pharynx, anchor cell and developing germline, substantial
expression outside of these tissues was also detected (Fig. 4F). This
is consistent with previous reports of “leaky” expression of lin-3
detected by smFISH in lin-15AB(e1763) mutant animals (Saffer et
al., 2011). We then examined lin-3 expression in sumv-1(aus3); lin-
15AB(n765) mutants and detected lin-3 transcripts in the pharynx,
anchor cell and germline, with some lin-3 transcripts also evident
outside of these tissues, albeit fewer than in the lin-15AB(n765)
mutant. To compare the distribution of lin-3 transcripts between
strains, the ﬂuorescent spots in the smFISH-treated animals were
counted (Table 4). These counts revealed a signiﬁcant increase in
“leaky” lin-3 expression in lin-15AB(n765) mutants compared with
wild-type animals (lin-15AB(n765) 106747 mRNA molecules;
wild-type 31714 mRNA molecules; po0.001, one-way ANOVA
with Sidak's post-test). In contrast, a signiﬁcant increase in “leaky”
lin-3 expressionwas not detected in either sumv-1(aus3) or sumv-1
(aus3); lin-15AB(n765) mutants compared with wild-type animals
(sumv-1(aus3) 34714 mRNA molecules; sumv-1(aus3); lin-15AB
(n765) 65739 mRNA molecules; not signiﬁcant, one-way ANOVA
with Sidak's post-test). Furthermore, the number of “leaky” lin-3
mRNA transcripts detected by smFISH in sumv-1(aus3); lin-15AB
(n765) mutants was signiﬁcantly less than the number detected in
lin-15AB(n765) mutant animals (po0.05, one-way ANOVA with
Sidak's post-test). This demonstrates that reduction of sumv-1
function by the aus3 allele suppresses the ectopic expression of
lin-3 in the lin-15AB(n765) synMuv mutant.
CTBP-1 does not substantially contribute to suppression of the
synMuv phenotype
Having demonstrated that SUMV-1 is required in the hypoder-
mis for the synMuv phenotype, we sought to clarify the mechan-
ism by which SUMV-1 affects synMuv activity in this tissue. One
possible mode of action is through ctbp-1. Since the sumv-1(aus3)
mutation gives rise to increased expression of the ausIs1[pctbp-1::
ctbp-1::gfp] transgene in hyp7, the sumv-1(aus3) mutation might
also affect expression of the endogenous ctbp-1 gene in this cell
type. If this was the case, then loss of sumv-1 function might lead
to increased levels of CTBP-1 in the hypodermis. These increased
levels of CTBP-1 might in turn contribute to suppression of the
synMuv phenotype, since we have previously shown that CTBP-1
is a transcriptional repressor protein (Nicholas et al., 2008). To test
this notion, we ﬁrst assessed the level of expression of endogenous
ctbp-1 in the sumv-1(aus3) mutant. Using real-time RT-PCR to
quantify ctbp-1 expression levels, we saw no difference in ctbp-1
expression between wild-type and aus3 mutant animals (Supple-
mentary materials, Fig. S3). Although this ﬁnding suggests that
reduction of sumv-1 function inﬂuences only the expression of the
ausIs1[pctbp-1::ctbp-1::gfp] transgene and not the endogenous
ctbp-1 locus, it is also likely that a difference in hypodermal
ctbp-1 would be undetectable against the background of high
levels of neuronally-expressed ctbp-1 using this method.
We therefore also took a genetic approach to assess the
involvement of ctbp-1 in the synMuv suppression phenotype of
the sumv-1 mutant. To this end, a strain carrying the synMuv
mutation lin-15AB(n765) together with the synMuv suppressor
mutation sumv-1(aus3) and a ctbp-1 mutation, ctbp-1(eg613), was
generated. The eg613 mutation affects a splice site and is likely a
hypomorphic allele (Bettinger et al., 2012; Reid, unpublished). If
ctbp-1 is required for the sumv-1-mediated suppression of syn-
Muv, reduction of ctbp-1 function would be expected to reduce the
synMuv suppression observed in the sumv-1(aus3); lin-15AB(n765)
strain. Indeed, a mild reduction in synMuv suppression was
observed, in that the proportion of animals displaying the Muv
phenotype in the presence of the ctbp-1(eg613) was moderately
increased, consistent with the view that CTBP-1 may contribute to
synMuv suppression (sumv-1(aus3); lin-15AB(n765) 13% (n¼344),
sumv-1(aus3); lin-15AB(n765) ctbp-1(eg613) 26% (n¼404)
(po0.0001 by Fisher's exact test), lin-15AB(n765) ctbp-1(eg613)
99% (n¼468)).
Table 3
Reduction of function of sumv-1, sumv-2 or dpy-30 does not suppress the synMuv phenotype in all synMuv mutants. The percentage of Muv animals was scored in each of
the mutant backgrounds following RNAi of each of the genes listed. As RNAi control, the E. coli strain HT115 transformed with the empty vector pL4440 was used. All RNAi
experiments were conducted at 20 1C.
Gene % Muv (n)
lin-15AB (n765) lin-36(n766);
lin-15A(n767)
lin-61(n3809);
lin-8(n2731)
lin-61(n3477);
lin-15A(n767)
lin-35(n745);
lin-15A(n767)
lin-35(n745);
lin-8(n111)
sumv-1(aus3);
lin-15AB(n765)
RNAi control 91 (482) 84 (536) 27 (2649) 50 (1700) 97 (455) 92 (245) 17 (666)
sumv-1 2 (538)nnnn 8 (887)nnnn 4 (1774)nnnn 29 (2093)nnnn 99 (380)n 97 (287)nn 6 (447)nnnn
sumv-2 3 (441)nnnn 69 (595)nnnn 4 (1738)nnnn 4 (2391)nnnn 90 (535)nnnn 91 (183) 12 (440)n
dpy-30 57 (119)nnnn 71 (337)nnnn 2 (2960)nnnn 4 (1644)nnnn 98 (294) 97 (257)nn 11 (448)nn
p-Values were derived from comparing data from mutant animals fed with RNAi of each gene to data from the respective RNAi control-treated mutant animals in a Fisher's
exact test.
n po0.05.
nn po0.01.
nnnn po0.0001.
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Fig. 4. SUMV-1 is required in the hypodermis for the synMuv phenotype. (A) Immunoblot showing the presence of a band corresponding to SUMV-1::V5 expressed under
the control of the dpy-7 promoter, probed using an anti-V5 antibody. Lower panel shows actin as a loading control. (B) The Multivulva phenotype was scored in sumv-1
(aus3); lin-15AB(n765) mutants with or without a transgene array expressing SUMV-1::V5 in the hypodermis. Data shown are mean7SD for three independently cultured
populations of a single transgenic line. (C) Merged bright ﬁeld and ﬂuorescence micrographs of adult C. elegans hermaphrodites. The sumv-1(aus3); lin-15AB(n765) mutant
(upper panel) has no pseudovulvae and the sumv-1(aus3); lin-15AB(n765) expressing SUMV-1::V5 in the hypodermis has two pseudovulvae (lower panel). Red ﬂuorescence
in the pharynx derives from a pmyo-2::mCherry reporter used as a transformation marker. Scale bar represents 200 mm. (D) smFISH of lin-3mRNA in L2-L3 animals. Each spot
represents a single mRNA molecule. Representative images for each analysed genotype are shown as maximum intensity projections of z-stacks of images along with the
corresponding DIC image. Images are composites formed from multiple segments. Scale bars represent 20 mm.
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To further characterise the involvement of ctbp-1 in the
synMuv suppression phenotype, we used DIC microscopy to
examine vulval induction in these mutants. As shown in Table 5,
while over-induction of vulval precursor cells is evident in lin-15AB
(n765) mutants (vulval induction score 5.070.1) compared with
wild type (370), there was no signiﬁcant difference in the vulval
induction scores between sumv-1(aus3); lin-15AB(n765) mutants
(3.270.1) and sumv-1(aus3); lin-15AB(n765) ctbp-1(eg613)
mutants (3.270.1). Thus, when examining vulval induction
directly, full ctbp-1 activity is not required for reduction of sumv-
1 to suppress the over-induction of vulval precursor cells due to
the lin-15AB(n765) mutation.
To resolve whether ctbp-1 plays any role in the suppression of
vulval over-induction observed in the sumv-1(aus3); lin-15AB
(n765) mutants, a null mutation of ctbp-1 should be tested, but
at present none is available. We therefore examined an additional
allele, tm5512, which is a deletion that removes the start codon of
one isoform of ctbp-1 (ctbp-1a) but leaves another isoform intact
(ctbp-1b) (Reid, unpublished). We found that this allele also had no
signiﬁcant effect on the vulval induction phenotype of sumv-1
(aus3); lin-15AB(n765) mutants (sumv-1(aus3); lin-15AB(n765)
ctbp-1(tm5512), 3.370.1 vulval induction score). This further
supports the conclusion that full ctbp-1 activity is not required
for the synMuv suppression arising from sumv-1 reduction of
function.
SUMV-1 interacts with DPY-30 and SUMV-2
In a further effort to understand the mechanism by which
SUMV-1 might inﬂuence synMuv activity, we queried the online
Search Tool for the Retrieval of Interacting Genes (STRING) for
SUMV-1 interactors (Szklarczyk et al., 2011). Reported in this
network is an association between SUMV-1 and DPY-30. This
association was identiﬁed as part of the C. elegans interactome,
which was described using a high-throughput yeast two-hybrid
system (Simonis et al., 2009). An additional query of the STRING
database for DPY-30 interactors, revealed that an association
between DPY-30 and an uncharacterised protein called F54D11.2
(henceforth called SUMV-2) had been identiﬁed in this same
interactome study. To conﬁrm and extend these ﬁndings, we
cloned full-length cDNAs encoding SUMV-1, SUMV-2 and DPY-30
and assessed the interactions of these proteins in yeast two-hybrid
assays. We found that SUMV-1 and DPY-30 interacted in this
system in both orientations of bait and prey protein (Fig. 5A). We
also found that SUMV-2 and DPY-30 interacted in both orienta-
tions of bait and prey proteins (Fig. 5A).
Given the association of both SUMV-1 and SUMV-2 with DPY-
30, we next tested whether SUMV-1 and SUMV-2 could physically
interact with each other. We found that SUMV-1 and SUMV-2
interacted in the yeast two-hybrid assay with SUMV-2 as bait and
SUMV-1 as prey (Fig. 5A). No interaction was detected when the
proteins were in the opposite orientations. This may be due to a
particular conformational constraint, a suggested source of false-
negatives in yeast two-hybrid assays (Stellberger et al., 2010).
Interestingly, like reduction of sumv-1, RNAi-mediated knock-
down of dpy-30 or of sumv-2 had been shown to suppress the Muv
phenotype of several synMuv double mutants by Cui et al.
(2006b). The physical association between DPY-30, SUMV-1 and
SUMV-2, suggested that the mechanism by which they inﬂuence
synMuv activity might be shared. We therefore assessed the
synMuv suppression activity of dpy-30 and sumv-2 RNAi and
compared this with that of sumv-1 reduction of function. As
shown in Table 3, like reduction of sumv-1 function, dpy-30 RNAi
and sumv-2 RNAi suppressed the synMuv phenotype of lin-15AB
(n765) and lin-36(n766); lin-15A(n767) mutants, consistent with
published observations (Cui et al., 2006b). Notably, like reduction
of sumv-1 function, dpy-30 RNAi and sumv-2 RNAi did not suppress
the synMuv phenotype of the lin-35(n745); lin-8(n111) mutant
(Table 3). These shared phenotypes support the proposal that the
synMuv suppression activity of dpy-30, sumv-1 and sumv-2 might
be mechanistically linked.
To further examine a potential functional relationship between
sumv-1, sumv-2 and dpy-30, we performed additional RNAi experi-
ments in the sumv-1(aus3); lin-15AB(n765) mutant background.
sumv-1 RNAi reduced the Muv phenotype in this mutant back-
ground, with RNAi treated animals showing only 6% Muv com-
pared with 17% Muv in empty-vector RNAi-treated animals. That
Table 4
Quantiﬁcation of lin-3 expression. smFISH was performed on L2–L3 stage animals to detect lin-3 transcript. Spots were counted on maximum intensity projections produced
from z-stacks of images taken for each animal. n represents the number of animals assayed for each genotype. Numbers represent the average number of spots counted in
each tissue (7S.D.). p-Values were calculated using a one-way ANOVA with Sidak's post-test.
Wild-type sumv-1(aus3) p-Value
sumv-1(aus3)
cf. wild-type
lin-15AB(n765) p-Value
lin-15AB(n765)
cf. wild-type
sumv-1(aus3);
lin-15AB(n765)
p-Value sumv-1(aus3);
lin-15AB(n765)
cf. wild-type
p-Value sumv-1(aus3);
lin-15AB(n765) cf.
lin-15AB(n765)
n 9 8 9 7
Anchor cell 1475 1572 n.s. 1779 n.s. 1676 n.s. n.s.
Germline 32718 51717 n.s. 73737 o0.05 61738 n.s. n.s.
Pharynx 222771 219754 n.s. 4207104 o0.001 3807125 o0.01 n.s.
Leaky 31714 34714 n.s. 106747 o0.001 65739 n.s. o0.05
Table 5
Reduction of function of ctbp-1 does not alter vulval induction in synMuv-
suppressed animals. Animals were cultured at 20 1C until L4 stage at which vulval
induction was assayed using differential interference contrast microscopy. n.s. not
signiﬁcant. p-Values were calculated by one-way ANOVA with Tukey post-test.
Comparisons shown are between.
Genotype Average # P(3–8).p vulval
fates7SE
n
wild type 370 37
sumv-1(aus3) 370 38
lin-15AB(n765) 5.070.1 34
sumv-1(aus3); lin-15AB(n765) 3.270.1 37
ctbp-1(eg613) 370 34
lin-15AB(n765) ctbp-1(eg613) 4.870.2 (n.s.a) 34
sumv-1(aus3); lin-15AB(n765) ctbp-1
(eg613)
3.270.1 (n.s.b) 37
ctbp-1(tm5512) 370 22
lin-15AB(n765) ctbp-1(tm5512) 5.270.1 (n.s.c) 34
sumv-1(aus3); lin-15AB(n765) ctbp-1
(tm5512)
3.370.1 (n.s.d) 37
a lin-15AB(n765) and lin-15AB(n765) ctbp-1(eg613).
b sumv-1(aus3); lin-15AB(n765) and sumv-1(aus3); lin-15AB(n765) ctbp-1
(eg613).
c lin-15AB(n765) and lin-15AB(n765) ctbp-1(tm5512).
d sumv-1(aus3); lin-15AB(n765) and sumv-1(aus3); lin-15AB(n765) ctbp-1
(tm5512).
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the synMuv suppression phenotype of the sumv-1(aus3) allele can
be enhanced by sumv-1 RNAi suggests that the aus3 allele is
hypomorphic. We also observed that sumv-2 RNAi and dpy-30
RNAi reduced the Muv phenotype of the sumv-1(aus3); lin-15AB
(n765) mutant to 12% and 11%, respectively (Table 3). In the case of
dpy-30, this is substantially less that the pentrance of the Muv
phenotype observed after RNAi-mediated knockdown in the lin-
15AB(n765) mutant background (57%). This enhancement of the
Fig. 5. SUMV-1 interacts with SUMV-2 and DPY-30, and SUMV-2 interacts with MYS-2. (A) Yeast two-hybrid assays were performed to examine the interactions between
SUMV-1, SUMV-2 and DPY-30 by fusing the test proteins to the C-terminus of either the Gal4 DNA binding domain (DBD) or the Gal4 activation domain (AD). Transformants
were selected on synthetic dropout (SD) plates lacking leucine and tryptophan, SD–L–T. Serial dilutions of overnight cultures were then transferred to SD–L–T and SD plates
lacking leucine, tryptophan and histidine (SD–H–L–T) and growth observed after 72 h at 30 1C. Growth on SD–H–L–T plates is indicative of a physical interaction between the
test proteins. Absence of growth on SD–H–L–T plates in columns 1, 3, 5, 7, 9 and 11 indicates that none of the Gal4DBD fusion proteins autoactivate the nutritional reporter
gene. Interactions between SUMV-1 and DPY-30 (columns 2 and 4), SUMV-2 and DPY-30 (columns 6 and 8), and SUMV-1 and SUMV-2 (columns 10 and 12) were assessed.
(B) Schematic representation of the SUMV-1 protein indicating the position of a conserved domain identiﬁed as pfam13891 (shown in black). An alignment of the sequence
of this domain in SUMV-1 with domains from human proteins KAT8 NSL2 and Ino80d is shown below. Putative zinc-coordinating amino acids are shown in red. C) SUMV-1,
SUMV-2 and DPY-30 may form a complex to antagonise the repression of lin-3 expression by the synMuv genes. SUMV-1 and SUMV-2 may form a complex with C. elegans
MOF ortholog MYS-2 in a similar manner to Drosophila NSL2 and NSL3. (D) Interaction between MYS-2 and SUMV-2. Yeast two-hybrid assays were performed as in (A).
Interactions between MYS-2 and SUMV-1, MYS-2 and SUMV-2, and MYS-2 and DPY-30 were assessed.
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synMuv suppression phenotype by combination of reduced func-
tion of both dpy-30 and sumv-1 is consistent with DPY-30 and
SUMV-1 working in the same pathway or complex in the context
of the synMuv phenotype.
The SUMV-1 protein contains a domain that is shared with
mammalian chromatin-associated proteins including KAT8 NSL2 and
SUMV-2 is homologous to mammalian KAT8 NSL3
Since SUMV-1 and SUMV-2 are uncharacterised nematode
proteins, we sought to identify any putative functional domains
within these proteins and to identify sequence homologues in other
species. We ﬁrst queried the conserved domain database and
identiﬁed in SUMV-1 a protein domain spanning amino acids
247–302, called pfam13891 (Marchler-Bauer et al., 2013). This
domain is annotated as a potential DNA binding domain of
chromatin remodelling proteins and helicases, although no func-
tional information is available. The domain is characterised by two
putative zinc ﬁngers with a zinc-coordinating signature of C3HC3H.
Other proteins that contain domains belonging to pfam13891
include the human proteins KAT8 NSL2 and Ino80d, each of which
contains two such domains (Fig. 5B). KAT8 NSL2 is a component of
the KAT8/MOF histone acetyltransferase complex (Mendjan et al.,
2006) and Ino80d is associated with the ATP-dependent chromatin
remodelling enzyme Ino80 (Chen et al., 2011; Jin et al., 2005).
A comparison of the pfam13891 sequences from SUMV-1, KAT8
NSL2 and Ino80d reveals that the ﬁrst putative zinc-coordinating
Cys residue is absent from the SUMV-1 sequence. Although the
domain annotation reports a double zinc ﬁnger motif, the greatest
similarity between the ﬁve pfam13891 sequences compared here is
observed in a central CCHC motif with the following consensus,
CX4LX4[F/H]CX2H[I/V]X2[D/N]X4–5FX2C, suggesting that this may be
the common structural or functional element of the pfam13891
domain.
We used BLAST to identify sequence homologues of SUMV-1 in
other species. These searches revealed homologues in other
Caenorhabditis species (Supplementary materials, Table S2), but
did not yield any clear homologues in other metazoans. An
additional search was therefore performed using the Domain
Enhanced Lookup Time Accelerated (Delta) BLAST function on
only the ﬁrst 400 amino acids of SUMV-1, which contain the
pfam13891 domain. This search identiﬁed KAT8 NSL2 as the
best hit in the human proteome. In the region from amino acids
15–304, SUMV-1 and KAT8 NSL2 share 23% amino acid identity
and 37% similarity. That is, the similarity between SUMV-1 and
KAT8 NSL2 extends beyond the zinc ﬁnger domain deﬁned by
pfam13891.
We sought to similarly characterise the SUMV-2 protein sequence.
Querying the conserved domain database did not reveal any con-
served domains in SUMV-2. BLAST searches identiﬁed sequence
homologues of SUMV-2 in other Caenorhabditis species (Supplemen-
tary materials, Table S3) and also identiﬁed a putative human
homologue, KAT8 NSL3; in the region from amino acids 670–955,
SUMV-2 and KAT8 NSL3 share 25% amino acid identity and 47%
similarity. OrthoList is a recently-compiled compendium of C. elegans
genes with human orthologues. Here, SUMV-2 is annotated as
orthologous to KAT8 NSL3, as determined by the orthology predic-
tion programs InParanoid and Ensemble Compara (Shaye and
Greenwald, 2011). Like KAT8 NSL2, with which SUMV-1 shares
similarity, KAT8 NSL3 is a component of the KAT8/MOF histone
acetyltransferase complex. SUMV-1 and SUMV-2 may therefore
function in a nematode KAT8/MOF-like complex (Fig. 5C). We
therefore examined whether reduction of function of mys-2, the
nematode homologue to KAT8/MOF (Sanjuan and Marin, 2001),
could suppress the synMuv phenotype of lin-15AB(n765). Using
RNAi, we found that knockdown of mys-2 suppressed the synMuv
phenotype of lin-15AB(n765) mutants (EV 96% Muv (n¼316); mys-2
RNAi 46% Muv (n¼1085), po0.0001 Fisher's exact test). We next
cloned the full-length cDNA encoding MYS-2 and used yeast two-
hybrid assays to test for physical interactions between MYS-2 and
SUMV-1, SUMV-2 or DPY-30. While MYS-2 did not interact with
SUMV-1 or DPY-30 in this system, a weak interaction between MYS-
2 and SUMV-2 was detected (Fig. 5D). Together these observations
demonstrate that MYS-2, SUMV-1 and SUMV-2 are required for the
synMuv phenotype and suggest that these three proteins may
function together in a KAT8/MOF-like complex.
Discussion
By screening for mutations that alter the expression of a
hypodermal reporter gene, we identiﬁed a mutant allele of
C34E10.8/sumv-1. Using this allele we have extended earlier
studies that identiﬁed a role for sumv-1 in vulval development
through a screen for RNAi treatments that suppress the multiple
vulva phenotype of a synMuv mutant (Cui et al., 2006b). We have
identiﬁed the cell type in which the synMuv suppressor SUMV-1
confers its activity. Furthermore, we have gained insight into
potential molecular mechanisms of synMuv suppression by iden-
tifying SUMV-2 and DPY-30 as interacting partners of SUMV-1 and
by demonstrating a requirement for the KAT8/MOF homologue
MYS-2 for the synMuv phenotype.
We have determined that SUMV-1 is required in the hypoder-
mis for the synMuv phenotype; reduction of function of sumv-1
suppresses the synMuv phenotype and re-expression of sumv-1
solely in the hypodermis restores the synMuv phenotype.
Although numerous genetic suppressors of the synMuv phenotype
have been identiﬁed (Andersen et al., 2006; Cui et al., 2006b;
Simms and Baillie, 2010; Wang et al., 2005), the cell type in which
synMuv suppressor activity occurs has, to date, been described for
only one of these, isw-1 (Andersen et al., 2006). Expression of isw-
1 solely in the hypodermis of an isw-1; synMuv mutant restored
the synMuv phenotype. isw-1 encodes the C. elegans ortholog of
Drosophila ISWI, an ATP-dependent chromatin-remodelling
enzyme homologous to Snf2/Swi2 of S. cerevisiae (Elfring et al.,
1994). Since the proteins encoded by the synMuv genes function in
the hypodermis to regulate vulval development, the earlier ﬁnding
that ISW-1 is required in the hypodermis for the synMuv pheno-
type, together with our data demonstrating a similar requirement
for SUMV-1, suggests that ISW-1 and SUMV-1, likely along with
other synMuv suppressors, may directly antagonise synMuv func-
tion in this tissue.
The synMuv genes encode transcriptional regulators, including
components of an E2F-Rb, dREAM/DRM and NuRD complexes
(reviewed in (Fay and Yochem, 2007)), which prevent ectopic
expression of the LIN-3 growth factor in the hypodermis. Although
the precise mechanism by which this is achieved has not yet been
clariﬁed, the identiﬁcation of a mutation in the promoter of the
lin-3 gene that acts as a dominant class A synMuv mutation by
increasing expression of lin-3, led to the proposal that the class A
synMuv genes speciﬁcally repress lin-3 expression either directly
or indirectly (Saffer et al., 2011). The class B synMuv genes, in
contrast, may repress lin-3 expression in the hypodermis as a
consequence of their more general role in preventing somatic cells
from adopting germline fates (Wang et al., 2005). That the class A
and B synMuv genes converge on regulation of expression of lin-3
suggested that the synMuv suppressors likely also regulate lin-3
expression. Consistent with this notion, we have found that loss of
sumv-1 function reduces the ectopic expression of lin-3 in a
synMuv mutant background.
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SUMV-1 and SUMV-2 resemble KAT8 NSL2 and KAT8 NSL3 and may
function in a KAT8/MOF-like complex
In light of the data presented here, we propose that SUMV-1
contributes to the control of lin-3 expression, either directly or
indirectly, by regulating chromatin. While any chromatin-
regulatory activity of SUMV-1 remains to be tested directly, several
lines of evidence suggest this as a possible mechanism by which
SUMV-1 may contribute to the synMuv phenotype. First, we found
SUMV-1 predominantly localised to the nucleus, as would be
required for interaction with chromatin. Second, we identiﬁed
within SUMV-1 a protein domain called pfam13891, a functionally
uncharacterised domain that has been identiﬁed in chromatin-
associated proteins from a range of metazoans (Marchler-Bauer et
al., 2013). Consisting of a putative double zinc ﬁnger motif, this
domain has been proposed to be a DNA binding domain. As such,
the pfam13891 domain may be required for targeting or stabilizing
the interaction of proteins with chromatin. Third, we have found
that the N-terminal region of SUMV-1 is similar to human protein
KAT8 NSL2, which associates with the histone acetyltransferase
KAT8/MOF (Mendjan et al., 2006). Fourth, we have shown that
SUMV-2 is a binding partner of SUMV-1 and identiﬁed SUMV-2 as
the nematode orthologue of KAT8 NSL3. Since KAT8 NSL3, like
KAT8 NSL2, associates with KAT8/MOF (Mendjan et al., 2006),
these observations suggest that nematode SUMV-1 and SUMV-2
may be components of a nematode KAT8/MOF-like complex.
KAT8/MOF belongs to the MYST family of histone acetyltrans-
ferases (Neal et al., 2000). This group of acetyltransferases share a
MYST domain (named for MOZ, YBF2, SAS2 and TIP60 (Borrow et
al., 1996)) some of which are histone H4 lysine 16-speciﬁc
acetyltransferases. H4K16 acetylation is associated with transcrip-
tionally active euchromatin (Shogren-Knaak et al., 2006). KAT8/
MOF was identiﬁed on the basis of sequence similarity with
Drosophila MOF (males absent on the ﬁrst), which itself was
initially discovered for its role in dosage compensation (Hilﬁker
et al., 1997). In this context Drosophila MOF associates with MSL
(male speciﬁc lethal) proteins. Afﬁnity puriﬁcation and mass
spectrometry was used to identify additional proteins associated
with the MSL complex in both Drosophila and humans, resulting in
the discovery of the NSL (non-speciﬁc lethal) proteins, named for
the lethality that is caused by P-element insertions in these genes
in Drosophila (Mendjan et al., 2006). Recent work has demon-
strated that the NSL proteins, in association with MOF, regulate
transcription of housekeeping genes in Drosophila (Feller et al.,
2012; Lam et al., 2012; Raja et al., 2010). The human NSL proteins
include KAT8 NSL2 and KAT8 NSL3 (Mendjan et al., 2006), with
which SUMV-1 and SUMV-2 share similarity, respectively. SUMV-1
and SUMV-2 may therefore associate with a nematode KAT8/MOF-
like MYST acetyltransferase to regulate gene expression. A nema-
tode orthologue of KAT8/MOF has been identiﬁed, called MYS-2
(K03D10.3) (Sanjuan and Marin, 2001), which plays roles in cell
fate maintenance (Shibata et al., 2010) and transgenerational
inheritance of RNAi (Vastenhouw et al., 2006). Here we have
shown that MYS-2 is also required for the synMuv phenotype and
that MYS-2 physically interacts with SUMV-2, supporting a role for
a nematode KAT8/MOF-like complex in vulval development.
In our assays, RNAi-mediated knockdown of sumv-1, sumv-2
and mys-2, and similarly reduction of sumv-1 function through the
aus3 allele gave rise to viable animals that are grossly phenotypi-
cally normal, with the effect of these manipulations on vulval
development only becoming apparent in synMuv mutant back-
grounds. These observations contrast with those in yeast, ﬂy and
mammalian systems where components of the KAT8/MOF-con-
taining NSL complex play global roles in chromatin regulation and
are essential for development. For instance, the yeast MOF homo-
logue Sas2 (Something About Silencing 2) is required for H4K16
acetylation of sub-telomeric chromatin, generating a boundary
that prevents the spreading of telomeric heterochromatin (Suka et
al., 2002). In mice, Mof is required for embryos to develop beyond
the expanded blastocyst stage; cells in Mof / blastocysts show
abnormal chromatin distribution and ultimately undergo apopto-
sis (Thomas et al., 2008). Similarly, as noted above, disruption of
Drosophila NSL2 and NSL3, with which SUMV-1 and SUMV-2 share
similarity, through P-element insertions, results in lethality
(Mendjan et al., 2006). Given these observations, it is somewhat
surprising that reduction of function of sumv-1, sumv-2 or mys-2 in
C. elegans does not have more dramatic consequences. It will be
necessary to examine the effect of null mutation of each of these
genes on chromatin regulation and development to determine
whether the essential and global roles played by their yeast, ﬂy
and mammalian counterparts are conserved in the nematode.
It is likely that the aus3 allele of sumv-1 that we have studied is
not null. The aus3 mutation introduces a premature stop codon,
resulting in a truncated protein of 680 amino acids. These ﬁrst 680
amino acids contain the pfam13891 protein domain, which is also
found in human KAT8 NSL2 and may be a functionally relevant
domain. Furthermore, the similarity between SUMV-1 and its
homologues in related nematode species, Caenorhabditis remanei,
Caenorhabditis brenneri and Caenorhabditis briggsae, is restricted to
the ﬁrst 650–750 amino acids of each of these proteins (Supple-
mentary materials, Table S2), suggesting again that this N-terminal
portion of the SUMV-1 protein may be functionally important.
Thus, it is likely that the truncated SUMV-1 protein encoded by the
aus3 allele retains some function.
We have also shown that both SUMV-1 and SUMV-2 interact
with DPY-30. The latter protein is homologous to human protein
hDPY-30, and is a component of the Set1/MLL histone methyl-
transferase complex which methylates lysine 4 of histone H3
(Pferdehirt et al., 2011). H3K4 trimethylation is associated with
actively expressed genes (Santos-Rosa et al., 2002). Like dpy-30,
genes encoding additional Set1/MLL complex components CFP-1
(homologous to mammalian CXXC ﬁnger protein 1 (CFP1)), WDR-5
(homologous to mammalian Wdr5) and HCF-1 (homologous to
mammalian host cell factor 1 (HCF1)) have been identiﬁed as
synMuv suppressors (Cui et al., 2006b). Components of the
nematode Set1/MLL-like complex play roles in germline develop-
ment and regulating expression of ajm-1, an apical junction
marker, during vulval development (Fisher et al., 2010; Li and
Kelly, 2011). The association of SUMV-1 and SUMV-2 with DPY-30
links a putative nematode KAT8/MOF-like H4K16 acetyltransferase
complex with the Set1/MLL-like H3K4 methyltransferase complex.
Interestingly, physical association between orthologous complexes
in humans has been demonstrated, and coordinated function of
the two complexes has been proposed (Dou et al., 2005). Indeed,
there is some overlap in the components of these two complexes:
Wdr5 and HCF1 have been identiﬁed as subunits not only of the
Set1/MLL histone methyltransferase complex but also of the KAT8/
MOF-containing NSL complex (Cai et al., 2010; Wysocka et al.,
2003, 2005). Furthermore, it was recently demonstrated that the
NSL complex promotes Set1/MLL-mediated histone H3K4
dimethylation in an acetylation-dependent manner, providing
mechanistic insight into the coordination of the activities of these
two chromatin modiﬁcation complexes (Zhao et al., 2013). The
interaction of both SUMV-1 and SUMV-2 with DPY-30 may also
facilitate this coordination. Whether these interactions are con-
served in the Drosophila and mammalian homologues (KAT8 NSL2,
KAT8 NSL3 and hDPY30) remains to be investigated.
In addition to being a component of the Set1/MLL complex,
DPY-30 is a component of the dosage compensation complex in C.
elegans (Pferdehirt et al., 2011). Dosage compensation in C. elegans
is achieved through global repression on the two hermaphrodite X
chromosomes (reviewed in (Meyer, 2010)). Consequently, a failure
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of dosage compensation results in the upregulation of X-encoded
transcripts (Vielle et al., 2012). Although dpy-30 was recently
identiﬁed as a synMuv suppressor through a genome-wide RNAi
screen (Cui et al., 2006b), the ﬁrst demonstration that loss of dpy-
30 function could suppress the synMuv phenotype of lin-15AB
(n765) mutants came from Hsu and Meyer (1994). In this and
other work, suppression of hypomorphic X-linked mutations
including lin-15AB(n765) was used as an assay of X-linked gene
expression, effectively assessing dosage compensation (Meneely
and Wood, 1987). The mechanism by which DPY-30 contributes to
the synMuv phenotype may therefore relate to its role in dosage
compensation rather than the Set1/MLL complex.
Suppression of synMuv phenotypes may depend on the strength of
the synMuv phenotype
It is curious that although reduction of function of sumv-1,
sumv-2 or dpy-30 suppressed the synMuv phenotype arising from
several different classes A and B synMuv double mutant combina-
tions, the synMuv suppressor capacity of sumv-1, sumv-2 and dpy-
30 did not extend to suppression of the synMuv phenotype of both
lin-35; lin-8 and lin-35; lin-15A double mutants. Speciﬁcity of
synMuv suppression has previously been reported for loss of
function of let-765. In this case, mutation of let-765 suppresses
the Muv phenotype of several synMuv mutants including lin-15AB
(n765) and lin-8(n111); lin-15B(n374) but does not suppress the
Muv phenotype of lin-53(n833); lin-15A(n767) mutant (Simms and
Baillie, 2010). While our observations might suggest that sumv-1,
sumv-2 and dpy-30 function upstream of lin-35 to regulate vulval
development, it is also possible that the relative strength of the
synMuv phenotype arising from these two double mutant combi-
nations is such that suppression can not be achieved through
partial loss of function of any of the factors, SUMV-1, SUMV-2 or
DPY-30. Seven gene inactivations that do suppress the lin-35; lin-8
synMuv phenotype have been reported (Wang et al., 2005),
demonstrating that this double mutant combination is not uni-
versally refractory to suppression. An indication that the strength
of the Muv phenotype can affect the observed level of suppression
comes from the observation that reduction of iswi-1 function
suppressed the Muv phenotype of a partial-loss-of-function lin-1
mutation and a null lin-31 mutation but not the Muv phenotype of
a null lin-1 mutation (Andersen et al., 2006).
synMuv suppressors regulate transgene expression
The hypodermal reporter that was used in our screen to
identify an allele of sumv-1 consists of a fusion of the transcrip-
tional repressor protein CTBP-1 with GFP, expressed under the
control of the ctbp-1 promoter. This reporter was generated by
microinjection of a fusion PCR product, which typically results in
the generation of high-copy extrachromosomal transgene arrays
(Stinchcomb et al., 1985). Such transgene arrays are subject to
silencing; in somatic cells fewer transcripts are produced per gene
in a high-copy array compared with a single-copy endogenous
gene (Mello and Fire, 1995) and in the germline robust silencing is
observed (Kelly et al., 1997). Interestingly, loss of function of
several class B synMuv genes including tam-1 results in hypersi-
lencing of such transgenes in somatic cells, which is called the Tam
(tandem array modiﬁer) phenotype (Hsieh et al., 1999; Tseng et al.,
2007). Furthermore, reduction of function of several synMuv
suppressors also results in suppression of the Tam phenotype
(Andersen et al., 2006; Cui et al., 2006b) suggesting that the
synMuv suppressors antagonise the activity of the synMuv genes
not only in the context of vulval development but also in the
regulation of transgene arrays. Several synMuv suppressors also
regulate germline transgene silencing; a let-858::gfp transgene is
normally expressed in somatic cells and silenced in the germline
(Kelly et al., 1997) but reduction of eight of the identiﬁed synMuv
suppressors, including sumv-2, by RNAi results in germline desi-
lencing (Cui et al., 2006b). Our observation of increased expression
of the ctbp-1::gfp transgene in the sumv-1 mutant may therefore
reﬂect a general role for sumv-1 in the regulation of high-copy
transgene arrays rather than a speciﬁc role in the control of
expression of ctbp-1. While we did not observe a change in the
level or pattern of expression of two other transgenes, that is a
myo-3::gfp or a lag-2::gfp reporter, in the sumv-1 mutant, regula-
tion of these reporter transgenes by sumv-1 could be revealed in
an appropriate genetic background. For instance, ectopic expres-
sion of the lag-2::gfp reporter in the intestine and hypodermis is
observed when the function of certain synMuv B genes is reduced
(Dufourcq et al., 2002; Poulin et al., 2005) and this ectopic
expression of lag-2::gfp as observed in lin-15B(n744) mutant
animals was partially suppressed by reduction of sumv-1 function
through RNAi (Cui et al., 2006b). Similarly, an effect of sumv-1
reduction of function on myo-3::gfp expression may be revealed in
a tam-1 loss of function background, where hypersilencing of
somatic transgenes is observed (Hsieh et al., 1999).
It is intriguing that reduction of sumv-1 function affects
expression of the ctbp-1::gfp reporter solely in the hypodermis
and not in neurons. This may reﬂect underlying differences in
chromatin regulation between the two tissues. The presence of
such tissue-speciﬁc differences was suggested by recent ﬁndings
that in many synMuv B mutants, where misexpression of germline
genes is observed in somatic tissues, the misexpression is most
prominent in the intestine and hypodermis (Wu et al., 2012). As
noted by Wu et al. (2012), unlike other tissues, cells of the
nematode intestine and hypodermis replicate even in late stages
of development, and also undergo endoreduplication (Flemming
et al., 2000; Hedgecock and White, 1985). These unique features
may require the maintenance of a different chromatin state (Wu et
al., 2012).
It is also interesting that increased hypodermal expression of
the ctbp-1::gfp reporter was observed as a result of reduction of
sumv-1 function. We have proposed that SUMV-1 may function
together with SUMV-2 and MYS-2 in a KAT/MOF-like histone
acetyltransferase complex, which is expected to positively regulate
gene expression. In this model, reduction of sumv-1 function
would result in increased expression of SUMV-1 target genes,
suggesting that the regulation of the ctbp-1::gfp reporter by
SUMV-1 is likely indirect. As noted above, SUMV-1 may contribute
more generally to mechanisms that regulate expression of trans-
genes. Indeed, Cui et al. (2006b) suggested that the synMuv B
genes and the synMuv suppressors, including sumv-1, may oppose
each other in the regulation of repetitive transgene silencing by
regulating heterochromatin formation. That is, that synMuv B
genes may repress expression of gene involved in heterochromatin
formation, while synMuv suppressors positively regulate these
genes, thus indirectly regulating repetitive transgenes. The
somatic silencing of transgenes that arises as a result of loss of
function of certain synMuv B genes (including lin-15B) occurs
through an RNAi-dependent mechanism (Lehner et al., 2006), and
animals carrying mutations in these same synMuv B genes are
hypersensitive to RNAi. Conversely, reduction of function of
several synMuv suppressor genes, including sumv-1, confers RNAi
resistance (Cui et al., 2006b), suggesting that SUMV-1 also reg-
ulates the RNAi machinery.
Concluding remarks
Our work deﬁnes a role for SUMV-1, SUMV-2 and MYS-2 as
antagonists of the activity of the synMuv proteins in C. elegans
vulval development. We propose that SUMV-1 and SUMV-2, which
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are similar to mammalian KAT8 NSL2 and KAT8 NSL3, respectively,
may function together with MYS-2 in a nematode KAT8/MOF-like
histone acetyltransferase complex.
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